Photostability studies on (±)-tramadol in a liquid formulation

BACKGROUND: Tramadol ((±)-TRA) is recommended for the treatment of mild to moderate cancer pain by the World Health Organization. An oral liquid formulation of (±)-TRA is preferable for patients with a compromised swallowing function. However, the stability of (±)-TRA in aqueous solution has yet to...

Descripción completa

Detalles Bibliográficos
Autores principales: Suno, Manabu, Ichihara, Hidenori, Ishino, Takahiro, Yamamoto, Kento, Yoshizaki, Yuta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677730/
https://www.ncbi.nlm.nih.gov/pubmed/26819716
http://dx.doi.org/10.1186/s40780-014-0003-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677730/
https://www.ncbi.nlm.nih.gov/pubmed/26819716
http://dx.doi.org/10.1186/s40780-014-0003-2

Ejemplares similares